You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
隴神戎發(300534.SZ):是一家集新藥研發、中藥加工和生產經營為一體的現代製藥企業
格隆匯 07-27 11:46

格隆匯7月27日丨有投資者向隴神戎發(300534.SZ)提問:請簡單介紹一下公司情況。

隴神戎發回復:隴神戎發作為甘肅省屬國有企業甘肅藥業投資集團有限公司的控股子公司,是一家集新藥研發、中藥加工和生產經營為一體的現代製藥企業、甘肅省戰略性新興產業骨幹企業、專精特新中小企業,多年來始終堅持“弘揚中藥文化,傳承中藥精髓、創新中藥產業”的企業願景。

公司主打產品元胡止痛滴丸為原國家中藥二類保護品種,國家重點新產品、“甘肅名牌”產品、國家基藥品種、國家醫保甲類藥品、全國獨家品種。

主打產品宣肺止嗽合劑為國家六類新藥、中藥二類保護品種、全國獨家品種,具有疏風宣肺,止咳化痰功效,產品止咳效果顯著、起效快、療程短,用於咳嗽屬風邪犯肺證,症見咳嗽、咽癢、鼻塞流涕、惡寒發熱、咯痰等。近年來經臨牀驗證其止咳效果獨特,先後被國家及二十多個省市納入專項中醫藥診療防治目錄、專家共識或推薦用藥,充分體現了中醫藥的獨特療效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account